Impaired immunogenicity of BNT162b2 anti-SARS-CoV-2 vaccine in patients treated for solid tumors고형 종양 치료를 받은 환자에서 BNT162b2 항-SARS-CoV-2 백신의 면역원성 손상 Published on 2021-08-012022-09-12 Journal: Annals of oncology : official journal of the Europ [키워드] anti-SARS-CoV-2 Impaired of BNT162b2 patients treated solid tumor Vaccine [저자] J Barrière, E Chamorey, Z Adjtoutah, O Castelnau, A Mahamat, S Marco, E Petit, A Leysalle, V Raimondi, M Carles [Category] Fulltext, MERS, 진단, PMC URL [DOI] 10.1016/j.annonc.2021.04.019 [Article Type] Article [Source] PMC All Keywords 【제목키워드】 Vaccine, anti-SARS-CoV-2, solid tumor, Impaired, of BNT162b2, patients treated,